$XBI $156.54 -3% 📉
Want to access our searchable database of catalysts and companies? Get access to BiopharmIQ for 30 days free, no credit card required. Check it out here!
Pipeline Updates
$RIGL +8% Collaboration with Eli Lilly for license agreement for Rigel's R552. source
$ATNX -4% US commercial launch of Klisyri. source
$TVTX +3% Sparsentan granted Orphan Designation by EMA. source